Table 6 Clinical and echocardiographic data of patients undergone to echocardiographic follow-up (n = 95)
| Â | Site of infection | p | ||
|---|---|---|---|---|
Aortic (n = 50) | Mitral (n = 39) | Tricuspid (n = 6) | ||
Gender (women), n (%) | 9 (18) | 7 (18) | 0 (0) | 0.5 |
Age (years), mean ± SD | 61.5 ± 14.8 | 60.3 ± 12.2 | 61.6 ± 12.5 | 0.7 |
Severe valvular dysfunction, n (%) | 23 (46) | 25 (64) | 3 (50) | 0.2 |
Paravalvular extension, n (%) | 13 (26) | 5 (13) | 0 (0) | 0.1 |
Vegetation length (mm), mean ± SD | 7.7 ± 6.2 | 10.2 ± 7.9 | 26.3 ± 13.3 | 0.008 |
Second infected valve, n (%) | 4 (8) | 5 (13) | 1 (17) | 0.6 |
Ejection Fraction (%), mean ± SD | 59.1 ± 8.0 | 60.9 ± 8.5 | 58.3 ± 6.6 | 0.5 |
TAPSE (mm), mean ± SD | 20.8 ± 6.2 | 23.2 ± 5.3 | 21.2 ± 6.9 | 0.2 |
Euroscore II | 7.3 ± 6.3 | 5.6 ± 9.1 | 4.3 ± 2.5 | 0.035 |
Surgery, n (%) | 42 (84) | 34 (87) | 6 (100) | 0.5 |
Ejection Fraction (%) at follow-up, mean ± SD | 58.9 ± 8.3 | 55.9 ± 9.1 | 55.1 ± 11.0 | 0.2 |
Severe valvular dysfunction at follow-up, n (%) | 0 (0) | 4 (10) | 0 (0) | 0.03 |